
LITS P/E Ratio
P/E Ratio as of Oct 29, 2025: -0.87
Average-0.9304
Median-0.9000
Minimum-1.12
Maximum-0.7700
-0.87
Past Month+0.20 (18.69%)
The P/E ratio for LITS is -0.87 as of Oct 29, 2025. This represents a increase of 97.73% compared to its 12-month average P/E ratio of -0.44. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
MEI Pharma Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
MEI Pharma Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing MEI Pharma Inc to industry peers.
MEI Pharma Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
MEI Pharma Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing MEI Pharma Inc to industry peers.
LITS P/E Ratio Insights
See MEI Pharma Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in LITS
Order type
Buy in
Order amount
Est. shares
0 shares
LITS P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2025 | $2.56 | -1.07 |
| Sep 2, 2025 | $4.85 | -1.02 |
| Aug 1, 2025 | $4.87 | -1.02 |
| Jul 1, 2025 | $2.36 | -0.50 |
| Jun 2, 2025 | $2.2152 | -0.47 |
| May 1, 2025 | $2.05 | -0.36 |
| Apr 1, 2025 | $2.15 | -0.37 |
| Mar 3, 2025 | $2.46 | -0.43 |
| Feb 3, 2025 | $2.76 | -0.39 |
| Jan 2, 2025 | $2.55 | -0.36 |
LITS End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.87 | +148.57% |
| 2024 | -0.35 | -137.23% |
| 2023 | 0.94 | -323.81% |
| 2022 | -0.42 | -86.79% |
| 2021 | -3.18 | -21.48% |
| 2020 | -4.05 | — |
FAQs About MEI Pharma Inc (LITS) P/E ratio
The latest P/E ratio of LITS is -0.87, as of Oct 29, 2025. This is calculated based on its current stock price and earnings per share (EPS).
MEI Pharma Inc’s last 12-month average P/E ratio is -0.44, compared to its current P/E ratio of -0.87. This reflects a increase of 97.73%.
MEI Pharma Inc’s current P/E ratio of -0.87 is higher than its last 12-month average P/E of -0.44. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
MEI Pharma Inc’s average P/E ratio over the last 3 years is 0.01. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
MEI Pharma Inc’s average P/E ratio over the last 5 years is -1.1. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.